7 September 2018 - Deborah Wilkes
Archived
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has reclassified certain glucosamine products as medicines. A spokesperson for the MHRA told OTCToolbox the decision had "now taken effect", and the agency would "work with companies in respect of the sale of products which are currently in the supply chain".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.